Latest News about INVA
Recent news which mentions INVA
   3 No-Brainer Stocks Under $10 to Buy for September
   
  
  
  September 02, 2022
  From InvestorPlace
 
   Stocks That Hit 52-Week Lows On Thursday
   
  
  
  July 28, 2022
  From Benzinga
 
   Overview Of Value Stocks In The Healthcare Sector
   
  
  
  July 25, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 From InvestorPlace
 From Benzinga
 From Benzinga
 
   5 Value Stocks To Watch In The Healthcare Sector
   
  
  
  June 27, 2022
  From Benzinga
 From Benzinga
 
   Overview Of Value Stocks In The Healthcare Sector
   
  
  
  March 28, 2022
  From Benzinga
 
   This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
   
  
  
  March 22, 2022
  From MarketWatch
 
   1 Healthcare Stock That Could Fly Higher After a Strong Q4
   
  
  
  March 05, 2022
  From Motley Fool
 
   12 Health Care Stocks Moving In Friday's Pre-Market Session
   
  
  
  February 11, 2022
  From Benzinga
 
   62 Biggest Movers From Yesterday
   
  
  
  February 11, 2022
  From Benzinga
 
   The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
   
  
  
  February 10, 2022
  From Benzinga
 
   Armata Pharma's Largest Shareholder Injects $45M For Its Bacteriophage Development
   
  
  
  February 10, 2022
  From Benzinga
 From InvestorPlace
 
   10 Stocks to Buy That Could Make You a Millionaire in 2022
   
  
  
  January 26, 2022
  From InvestorPlace
 
   7 of the Top-Rated Pharmaceutical Stocks for Q1
   
  
  
  January 18, 2022
  From InvestorPlace
 
   5 Value Stocks In The Healthcare Sector
   
  
  
  December 20, 2021
  From Benzinga
 
   5 Value Stocks To Watch In The Healthcare Sector
   
  
  
  December 06, 2021
  From Benzinga
 
   7 Top-Rated Pharmaceutical Stocks To Invest in for October
   
  
  
  October 04, 2021
  From InvestorPlace
 
   The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
   
  
  
  September 30, 2021
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

